OFG
REGN icon

OmniStar Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History

OmniStar Financial Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-57
Closed -$28K – 271
2020
Q1 		$28K Buy
+57
New +$23.5K 0.03% 161

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

OmniStar Financial Group's REGN Position: Q2 2020 in Review

OmniStar Financial Group sold out of Regeneron Pharmaceuticals (REGN) in Q2 2020, closing a stake of 57 shares — an estimated $28K sold.

OmniStar Financial Group first reported a position in REGN in Q1 2020 and held it in 1 quarter. The position peaked at $28K in Q1 2020. 932 funds tracked by Wall St. Rank hold REGN as of Q2 2020.

  • OmniStar Financial Group reported no remaining Regeneron Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • OmniStar Financial Group sold 57 Regeneron Pharmaceuticals shares in Q2 2020, an estimated $28K.
  • OmniStar Financial Group first reported a position in Regeneron Pharmaceuticals in Q1 2020 and held it in 1 quarter.
  • OmniStar Financial Group's Regeneron Pharmaceuticals position peaked at $28K in Q1 2020.
  • 932 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2020.

Based on OmniStar Financial Group's 13F filing for Q2 2020, filed 6 Jul 2020.